Physician

Steven Jay Ayres, M.D.

According to 2025 Medicare claims, Steven Ayres, M.D. (NPI: 1265488464) practices gastroenterology in the Great Falls, MT market, with the plurality of this provider's patient population coming from Cascade, MT. This provider's primary affiliated billing organization is BENEFIS HOSPITALS INC (NPI: 1780968974; TIN: 810232122) and primary practice location at 59405-5161.

Ayres' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 448 traditional Medicare patients, billed 711 HCPCS/CPT codes, and received $68,062 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 712 prescription claims across 143 beneficiaries totaling $141,043 in drug costs, led by Xifaxan (Rifaximin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,376,989 to $141,043. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$78K$156K2015 Medicare payment: $126,386 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $107,674 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $105,395 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $155,952 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $136,479 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $128,651 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $123,153 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $130,963 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $123,661 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $68,062 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015595961$126,386
2016559897$107,674
20175561,339$105,395
20187431,811$155,952
20196751,325$136,479
20206331,229$128,651
20216631,138$123,153
20227101,216$130,963
20236991,210$123,661
2024448711$68,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$688K$1.4M2015 Drug cost: $1,376,989 (USD; Tot_Drug_Cst)2016 Drug cost: $184,188 (USD; Tot_Drug_Cst)2017 Drug cost: $114,612 (USD; Tot_Drug_Cst)2018 Drug cost: $69,725 (USD; Tot_Drug_Cst)2019 Drug cost: $44,381 (USD; Tot_Drug_Cst)2020 Drug cost: $51,550 (USD; Tot_Drug_Cst)2021 Drug cost: $52,751 (USD; Tot_Drug_Cst)2022 Drug cost: $92,468 (USD; Tot_Drug_Cst)2023 Drug cost: $352,717 (USD; Tot_Drug_Cst)2024 Drug cost: $141,043 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015353798$1,376,989
2016405787$184,188
2017367777$114,612
2018303687$69,725
2019129428$44,381
2020144558$51,550
2021151576$52,751
2022146571$92,468
2023169820$352,717
2024143712$141,043

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare106106$177
G0121Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk4646$175
43235Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope4545$87
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope7274$56
91010Study of esophagus to assess movement3939$46

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XifaxanRifaximin26764$78,874
MercaptopurineMercaptopurine15668$4,420
Pantoprazole SodiumPantoprazole Sodium22110,305$2,370
Budesonide DrBudesonide261,000$2,332
Colestipol HclColestipol Hcl24794$2,133

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Steven Jay Ayres, M.D.?

Tedicare shows public-source Medicare data for Steven Jay Ayres, M.D. (NPI 1265488464), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Jay Ayres, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven Jay Ayres, M.D.?

Steven Jay Ayres, M.D. is linked to BENEFIS HOSPITALS INC (billing NPI 1780968974) in the available physician profile data.

Does Steven Jay Ayres, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.